Literature DB >> 15579725

Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema.

Nicholas S Hopkinson1, Tudor P Toma, David M Hansell, Peter Goldstraw, John Moxham, Duncan M Geddes, Michael I Polkey.   

Abstract

Endobronchial valve placement improves pulmonary function in some patients with chronic obstructive pulmonary disease, but its effects on exercise physiology have not been investigated. In 19 patients with a mean (SD) FEV(1) of 28.4 (11.9)% predicted, studied before and 4 weeks after unilateral valve insertion, functional residual capacity decreased from 7.1 (1.5) to 6.6 (1.7) L (p = 0.03) and diffusing capacity rose from 3.3 (1.1) to 3.7 (1.2) mmol . minute(-1) . kPa(-1) (p = 0.03). Cycle endurance time at 80% of peak workload increased from 227 (129) to 315 (195) seconds (p = 0.03). This was associated with a reduction in end-expiratory lung volume at peak exercise from 7.6 (1.6) to 7.2 (1.7) L (p = 0.03). Using stepwise logistic regression analysis, a model containing changes in transfer factor and resting inspiratory capacity explained 81% of the variation in change in exercise time (p < 0.0001). The same variables were retained if the five patients with radiologic atelectasis were excluded from analysis. In a subgroup of patients in whom invasive measurements were performed, improvement in exercise capacity was associated with a reduction in lung compliance (r(2) = 0.43; p = 0.03) and isotime esophageal pressure-time product (r(2) = 0.47; p = 0.03). Endobronchial valve placement can improve lung volumes and gas transfer in patients with chronic obstructive pulmonary disease and prolong exercise time by reducing dynamic hyperinflation.

Entities:  

Mesh:

Year:  2004        PMID: 15579725     DOI: 10.1164/rccm.200407-961OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  40 in total

Review 1.  ABC of chronic obstructive pulmonary disease.Non-pharmacological management.

Authors:  Graeme P Currie; J Graham Douglas
Journal:  BMJ       Date:  2006-06-10

2.  Collateral ventilation.

Authors:  E J Cetti; A J Moore; D M Geddes
Journal:  Thorax       Date:  2006-05       Impact factor: 9.139

Review 3.  Valve therapy in patients with emphysematous type of chronic obstructive pulmonary disease (COPD): from randomized trials to patient selection in clinical practice.

Authors:  Arschang Valipour
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

4.  Physiologic basis for improved pulmonary function after lung volume reduction.

Authors:  Henry E Fessler; Steven M Scharf; Edward P Ingenito; Robert J McKenna; Amir Sharafkhaneh
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

5.  Extrinsic Threshold PEEP Reduces Post-exercise Dyspnea in COPD Patients: A Placebo-controlled, Double-blind Cross-over Study.

Authors:  A Daniel Martin; Paul W Davenport
Journal:  Cardiopulm Phys Ther J       Date:  2011-09

Review 6.  The Clinical Significance of Collateral Ventilation.

Authors:  Peter B Terry; Richard J Traystman
Journal:  Ann Am Thorac Soc       Date:  2016-12

7.  One-Year Follow-Up after Endobronchial Valve Treatment in Patients with Emphysema without Collateral Ventilation Treated in the STELVIO Trial.

Authors:  Karin Klooster; Jorine E Hartman; Nick H T Ten Hacken; Dirk-Jan Slebos
Journal:  Respiration       Date:  2016-12-15       Impact factor: 3.580

Review 8.  Bronchoscopic lung volume reduction in severe emphysema.

Authors:  Edward P Ingenito; Douglas E Wood; James P Utz
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

9.  A multicenter pilot study of a bronchial valve for the treatment of severe emphysema.

Authors:  D H Sterman; A C Mehta; D E Wood; P N Mathur; R J McKenna; D E Ost; J D Truwit; P Diaz; M M Wahidi; R Cerfolio; R Maxfield; A I Musani; T Gildea; F Sheski; M Machuzak; A R Haas; H X Gonzalez; S C Springmeyer
Journal:  Respiration       Date:  2009-11-17       Impact factor: 3.580

Review 10.  Hyperinflation and its management in COPD.

Authors:  Luis Puente-Maestu; William W Stringer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.